Cargando…
miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL
First-line treatment for osteosarcoma includes chemotherapy and surgery. However, the five-year survival rate of refractory osteosarcoma remains unsatisfactory. Osteosarcoma cancer stem cells, possessing stemness and chemoresistance, are one of the critical causes of poor response to chemotherapy. E...
Autores principales: | Zhang, Jingyong, Wang, Shubao, Bai, Yang, Ali, Aasi Mohammad, Deng, Jiewen, Chen, Yushi, Fu, Yonghui, He, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917813/ https://www.ncbi.nlm.nih.gov/pubmed/36769824 http://dx.doi.org/10.3390/jcm12031177 |
Ejemplares similares
-
Exosomal miR-331-3p derived from chemoresistant osteosarcoma cells induces chemoresistance through autophagy
por: Meng, Chenyang, et al.
Publicado: (2023) -
TUSC8 inhibits the development of osteosarcoma by sponging miR-197-3p and targeting EHD2
por: Fan, Hongwu, et al.
Publicado: (2020) -
TUSC8 inhibits the development of osteosarcoma by sponging miR-197-3p and targeting EHD2
por: Fan, Hongwu, et al.
Publicado: (2021) -
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
por: Song, Bo, et al.
Publicado: (2010) -
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
por: Song, Bo, et al.
Publicado: (2009)